Company Snapshot: Nemaura Medical Inc.

NMRD
Last	Change	Volume	High	Low

Company Overview

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes specialty medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. The company was founded in 2009 and is headquartered in Loughborough, the United Kingdom.

Client News

1. Jan 27 2023 Nemaura Medical Announces Pricing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private Placement
2. Jan 26 2023 Nemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleet
3. Jan 24 2023 Nemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of Participants
4. Jan 11 2023 Nemaura Medical to Present at the Sidoti & Co. Micro Cap Virtual Conference